| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/23/1998 | US5769080 Gas filled liposomes and stabilized gas bubbles and their use as ultrasonic contrast agents |
| 06/23/1998 | CA2166296C Stabilized pharmaceutical peptide compositions |
| 06/23/1998 | CA2119636C Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives |
| 06/23/1998 | CA2056384C Bioerodible polymers for drug delivery in bone |
| 06/23/1998 | CA2038579C Utilization of enzymes |
| 06/18/1998 | WO1998026008A1 Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use |
| 06/18/1998 | WO1998025971A1 Monovalent antibody fragments |
| 06/18/1998 | WO1998025649A1 Use of low molecular weight amino alcohols in ophthalmic compositions |
| 06/18/1998 | WO1998025642A2 Pharmaceutical formulations comprising a water-insoluble complex for sustained drug delivery |
| 06/18/1998 | WO1998025638A1 Use of plant extract for inhibition of haemophilus influenzae |
| 06/18/1998 | WO1998025621A1 Improved pharmaceutical compositions |
| 06/18/1998 | WO1998025610A1 Use of green porphyrins for the manufacture of a medicament for the treatment of secondary cataracts |
| 06/18/1998 | WO1998025599A1 An oil composition of dihydropolyprenols |
| 06/18/1998 | WO1998025595A2 Aqueous drink composition comprising ibuprofen |
| 06/18/1998 | WO1998025590A2 Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance |
| 06/18/1998 | WO1998025589A1 Active agent transport systems |
| 06/18/1998 | WO1998025575A2 Improved hydrogel composition |
| 06/18/1998 | WO1998018477A3 Pharmaceutical compositions containing lamivudine and zidovudine |
| 06/18/1998 | WO1998017310A3 Polyanionic polymers as adjuvants for mucosal immunization |
| 06/18/1998 | WO1998015293A3 Targeted addition of soluble polymers to recombinant proteins |
| 06/18/1998 | WO1998013024A3 Hyaluronic drug delivery system |
| 06/18/1998 | WO1998005364A3 Improvements in or relating to contrast agents |
| 06/18/1998 | WO1998005361A3 Long-acting drugs and pharmaceutical compositions comprising them |
| 06/18/1998 | DE19652257A1 Einzeln dosierte, bei Kontakt mit Flüssigkeit schnell zerfallende, wirkstoff- und insbesondere aromastoffhaltige, folienförmige Darreichnungsform Single-dose, when in contact with liquid rapidly disintegrating, and in particular active ingredient-aromatic-based sheet-shaped Darreichnungsform |
| 06/18/1998 | DE19651681A1 Stabile, wäßrige Dispersionen und stabile, wasserdispergierbare Trockenpulver von Xanthopyllen, deren Herstellung und Verwendung Stable, aqueous dispersions and stable, water-dispersible dry powder of Xanthopyllen, their preparation and use |
| 06/18/1998 | CA2621857A1 Peptides and compounds that bind to a receptor |
| 06/18/1998 | CA2274847A1 Pharmaceutical formulations for sustained drug delivery |
| 06/18/1998 | CA2274832A1 Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance |
| 06/18/1998 | CA2269680A1 An oil composition of dihydropolyprenols |
| 06/17/1998 | EP0848011A1 Method of coupling polysaccharides to proteins |
| 06/17/1998 | EP0847280A2 Compositions and their uses |
| 06/17/1998 | EP0847273A2 Improved pharmaceutical ion exchange resin composition |
| 06/17/1998 | EP0847270A1 Use of acrylic copolymers in cosmetics and compositions used |
| 06/17/1998 | EP0847268A1 Refreshing compositions |
| 06/17/1998 | EP0847242A1 Sugar-free dragee-like products |
| 06/17/1998 | EP0847240A1 Novel embolizing compositions |
| 06/17/1998 | EP0714415B1 Aqueous copolymer dispersions |
| 06/17/1998 | EP0684814B1 Compositions for oral delivery of active agents |
| 06/17/1998 | EP0611376B1 Production and use of multimeric hemoglobins |
| 06/17/1998 | CN1185115A 多粘菌素轭合物 Polymyxin conjugates |
| 06/17/1998 | CN1185112A Use of flavanolignanes for the prepn. of medicametns with antiproliferative activity in uterus, ovary and breast |
| 06/17/1998 | CN1185107A Pharmaceutical composition contg. proton pump inhititors |
| 06/17/1998 | CN1185104A Diltiazem controlled release formulation |
| 06/16/1998 | US5767285 Linkers useful for the synthesis of conjugates of methyltrithio antitumor agents |
| 06/16/1998 | US5767284 Reacting polyoxyalkylene compound having terminal carboxyl group with n-hydroxysuccinimide in inert solvent in presence of dicyclohexylcarbodiimide, filtering, crystallizing by adding isopropanol |
| 06/16/1998 | US5767246 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
| 06/16/1998 | US5767161 Ibuprofen, ethanol, propylene glycol |
| 06/16/1998 | US5767143 Eye drops containing single polymer, pilocarpine, beta-blocking agent, carrier, having specified ph and viscosity |
| 06/16/1998 | US5767112 Acidic mixture for injection comprising neuromuscular blocking agent and zwitterion having isoelectric point greater than 7; shelf life, anesthetic |
| 06/16/1998 | US5767109 Complexing urushiols |
| 06/16/1998 | US5767099 Containing lipophilic groups derived from steroids |
| 06/16/1998 | US5767095 Algicide |
| 06/16/1998 | US5767089 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 06/16/1998 | US5767087 Administering purified glutamic acid-tryptophan dipeptide toincrease number of lymphocytes or karyocytes in non-human animal |
| 06/16/1998 | US5767072 Therapeutic compositions comprising a CD4 peptide and methods of treatment of HIV infections |
| 06/16/1998 | US5766902 Transfection process |
| 06/16/1998 | US5766633 Modified amino acid carrier, bioactive peptides |
| 06/16/1998 | US5766629 Nonionic surfactant, alkanol |
| 06/16/1998 | US5766627 Incorporating into hydrohalic acid-free oil in water emulsiona mineral or organic acid to control drug delivery |
| 06/16/1998 | US5766622 Inhibiting undesirable taste in oral compositions |
| 06/16/1998 | US5766619 Pharmaceutical dosage form for ocular administration and preparation process |
| 06/16/1998 | US5766612 Use of endgroup-capped fatty amide alkoxylates |
| 06/16/1998 | US5766582 Storage stability; mixture with buffer, stabilizer and chelate compound |
| 06/16/1998 | US5766581 Increasing platelet number with polypeptide molecules attached to polyethylene glycol |
| 06/16/1998 | US5766580 Controlled release of miotic and mydriatic drugs in the anterior chamber |
| 06/16/1998 | US5766520 Preservation by foam formation |
| 06/16/1998 | US5766473 Enzyme loaded hydrophilic porous structure for protecting oxygen sensitive products and method for preparing same |
| 06/16/1998 | CA2162470C Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance |
| 06/16/1998 | CA2119154C Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| 06/11/1998 | WO1998024936A1 Macromolecule-lipid complexes and methods for making and using |
| 06/11/1998 | WO1998024917A1 Thrombolytic agents with antithrombotic activity |
| 06/11/1998 | WO1998024504A2 Device for local administration of solid and semisolid pharmaceutical formulations, sustained-release pharmaceutical formulations for parenteral administration and method of preparation |
| 06/11/1998 | WO1998024482A2 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them |
| 06/11/1998 | WO1998024478A2 Tumour therapy |
| 06/11/1998 | WO1998024470A1 Topical preparation for introducing peptidaceous pharmacons in living organisms |
| 06/11/1998 | WO1998024436A2 Gel formulations for topical drug delivery |
| 06/11/1998 | WO1998024430A1 Pharmaceutical compositions containing n-sulphonyl indolin derivatives |
| 06/11/1998 | WO1998024427A2 Compositions and methods for treating or preventing inflammatory diseases |
| 06/11/1998 | WO1998024414A1 Pharmaceutical suspension systems |
| 06/11/1998 | WO1998024316A1 Anti-first-pass effect compounds and citrus extract |
| 06/11/1998 | WO1998017319A3 Platelet substitutes and conjugation methods suitable for their preparation |
| 06/11/1998 | CA2607067A1 Compositions and methods for treating or preventing inflammatory diseases |
| 06/11/1998 | CA2273990A1 Pharmaceutical compositions containing n-sulphonyl indolin derivatives |
| 06/11/1998 | CA2273218A1 Tumour therapy |
| 06/11/1998 | CA2272604A1 Topical preparation for introducing peptidaceous pharmacons in living organisms |
| 06/10/1998 | EP0846680A1 Cationic lipids for gene therapy |
| 06/10/1998 | EP0846466A2 Compositions for the treatment of rheumatoid-based arthritic diseases |
| 06/10/1998 | EP0846000A1 Hyperbranched polymers |
| 06/10/1998 | EP0845999A1 Method for the production of tablets by pressing and tablets produced by the method |
| 06/10/1998 | EP0845993A1 Use of plasminogene activators to stimulate local bone growth |
| 06/10/1998 | EP0845981A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
| 06/10/1998 | EP0831817A4 Antigen-processing cell-targeted conjugates |
| 06/10/1998 | EP0773975A4 Conducting electroactive biomaterials |
| 06/10/1998 | EP0746317B1 Sublingual or buccal pharmaceutical composition |
| 06/10/1998 | EP0733106A4 Plant arabinogalactan protein (agp) genes |
| 06/10/1998 | DE19652374A1 Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung Use of endothelin-conjugates in therapy, new endothelin conjugates, compositions comprising them, and to processes for their preparation |
| 06/10/1998 | CN1184484A Novel anti-AIDS immunotoxins |
| 06/10/1998 | CN1184431A Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence |
| 06/10/1998 | CN1184421A Treatment of inflammatory bowel disease using oral dosage forms of omega -3 polyunsaturated acids |
| 06/10/1998 | CN1184420A Production scale method of forming microparticles |